Agios Pharma (AGIO) Presents Translational Data to Further Characterize the Role of TIBSOVO Treatment in IDH1 Mutant AML
Go back to Agios Pharma (AGIO) Presents Translational Data to Further Characterize the Role of TIBSOVO Treatment in IDH1 Mutant AML| AGIOS PHARM (NASDAQ: AGIO) | Delayed: 29.46 +0.74 (2.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.72 | 52 Week High | $71.49 | |||
| Open | $28.80 | 52 Week Low | $33.50 | |||
| Day High | $30.23 | P/E | N/A | |||
| Day Low | $28.51 | EPS | $-1.18 | |||
| Volume | 1,141,118 | |||||
